Top Banner
1130-0108/2015/107/567-568 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS COPYRIGHT © 2015 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid Vol. 107, N.º 9, pp. 567-568, 2015 PICTURES IN DIGESTIVE PATHOLOGY Jejunal plasmablastic lymphoma presenting as obscure overt gastrointestinal bleeding: Diagnosis by wireless capsule endoscopy Pedro Magalhães-Costa, Miguel Bispo, Leopoldo Matos and Cristina Chagas Gastroenterology Department. Hospital Egas Moniz. Centro Hospitalar Lisboa Ocidental. Lisboa, Portugal CASE REPORT A 43 year-old male, diagnosed with acquired immune de- ficiency syndrome (under highly active antiretroviral therapy), presented with intermittent and recurrent melena. Physical ex- amination was unremarkable. Labs revealed a severe microcytic anemia –serum hemoglobin (Hb) = 5.1 g/dL. Upper gastroin- testinal endoscopy and ileocolonoscopy disregarded any poten- tially bleeding lesion. In the ward the patient kept the clinical picture, thus a wireless capsule endoscopy (WCE) was per- formed. The examiner noted in the mid-jejunum, a circumfer- ential, stricturing and ulcerated lesion (Fig. 1A and C), with ac- tive oozing bleeding (Fig. 1B). An abdomino-pelvic computed tomography (CT) (Fig. 2A and B) scan revealed a small-bowel mass in the pelvic cavity. Also, a round and hyperintense im- age with many artefactual effects associated with the previous- ly described mass was noted (the retained WCE device). The patient developed severe obstructive symptoms and an urgent surgical approach was deemed necessary. The resected speci- men consisted of a 16 cm long segment of jejunum centered by a neoplastic mass, stricturing and ulcerated with 8 cm of larger longitudinal axis. Mesenteric ganglia were not committed and the surgical margins were free (R0 resection). Microscopy (Fig. 3A-E) visualized a diffuse lymphoma with large cell nucleus. The immunohistochemistry stain (IHQ) profile was positive for (cluster of differentiation) CD138 and CD79a; negative for CD30, CD20, CD19, CD10, (B-cell lymphoma) BCL2, BCL6, anaplastic lymphoma kinase (ALK), CD3, EMA (MUC1): Ep- ithelial membrane antigen (AE1AE3) and EMA. On the basis of these morphologic and IHQ characteristics, the pathological diagnosis of plasmablastic lymphoma was made. The patient re- ceived 6 cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) and, after 32 months of follow-up, his disease is in remission. DISCUSSION There are few case reports of plasmablastic lymphoma (PBL) which had occurred in extra-oral locations like the small-bowel (1-3). Although PBL is usually typified as being an high-grade malignant lymphoma and known by their diffuse infiltrative growth, high mitotic rate and a dismal prognosis, in this case, an appropriate multidisciplinary approach allowed to an early diagnosis and subsequent treatment of the neoplasm. ACKNOWLEDGMENTS Presented as a poster at RICE 2013 (XI Reunión Ibérica de Cápsula Endoscópica), 12 January 2013, Valencia, Spain. Fig. 1. Capsule endoscopy findings. A and C. A circumferential, stricturing and ulcerated lesion was found. B. Oozing active bleeding from the lesion. A B C
2

Jejunal plasmablastic lymphoma presenting as obscure overt ...scielo.isciii.es/pdf/diges/v107n9/imagenes1.pdf · There are few case reports of plasmablastic lymphoma (PBL) which had

Dec 28, 2019

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Jejunal plasmablastic lymphoma presenting as obscure overt ...scielo.isciii.es/pdf/diges/v107n9/imagenes1.pdf · There are few case reports of plasmablastic lymphoma (PBL) which had

1130-0108/2015/107/567-568Revista española de enfeRmedades digestivasCopyRight © 2015 aRán ediCiones, s. l.

Rev esp enfeRm dig (MadridVol. 107, N.º 9, pp. 567-568, 2015

PICTURES IN DIGESTIVE PATHOLOGY

Jejunal plasmablastic lymphoma presenting as obscure overt gastrointestinal bleeding: Diagnosis by wireless capsule endoscopyPedro Magalhães-Costa, Miguel Bispo, Leopoldo Matos and Cristina Chagas

Gastroenterology Department. Hospital Egas Moniz. Centro Hospitalar Lisboa Ocidental. Lisboa, Portugal

CASE REPORT

A 43 year-old male, diagnosed with acquired immune de-ficiency syndrome (under highly active antiretroviral therapy), presented with intermittent and recurrent melena. Physical ex-amination was unremarkable. Labs revealed a severe microcytic anemia –serum hemoglobin (Hb) = 5.1 g/dL. Upper gastroin-testinal endoscopy and ileocolonoscopy disregarded any poten-tially bleeding lesion. In the ward the patient kept the clinical picture, thus a wireless capsule endoscopy (WCE) was per-formed. The examiner noted in the mid-jejunum, a circumfer-ential, stricturing and ulcerated lesion (Fig. 1A and C), with ac-tive oozing bleeding (Fig. 1B). An abdomino-pelvic computed tomography (CT) (Fig. 2A and B) scan revealed a small-bowel mass in the pelvic cavity. Also, a round and hyperintense im-age with many artefactual effects associated with the previous-ly described mass was noted (the retained WCE device). The patient developed severe obstructive symptoms and an urgent surgical approach was deemed necessary. The resected speci-men consisted of a 16 cm long segment of jejunum centered by a neoplastic mass, stricturing and ulcerated with 8 cm of larger longitudinal axis. Mesenteric ganglia were not committed and the surgical margins were free (R0 resection). Microscopy (Fig. 3A-E) visualized a diffuse lymphoma with large cell nucleus. The immunohistochemistry stain (IHQ) profile was positive for (cluster of differentiation) CD138 and CD79a; negative for CD30, CD20, CD19, CD10, (B-cell lymphoma) BCL2, BCL6, anaplastic lymphoma kinase (ALK), CD3, EMA (MUC1): Ep-ithelial membrane antigen (AE1AE3) and EMA. On the basis of these morphologic and IHQ characteristics, the pathological diagnosis of plasmablastic lymphoma was made. The patient re-ceived 6 cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) and, after 32 months of follow-up, his disease is in remission.

DISCUSSION

There are few case reports of plasmablastic lymphoma (PBL) which had occurred in extra-oral loca tions like the small-bowel (1-3). Although PBL is usually typified as being an high-grade malignant lymphoma and known by their diffuse infiltrative growth, high mitotic rate and a dismal prognosis, in this case, an appropriate multidisciplinary approach allowed to an early diagnosis and subsequent treatment of the neoplasm.

ACKNOWLEDGMENTS

Presented as a poster at RICE 2013 (XI Reunión Ibérica de Cápsula Endoscópica), 12 January 2013, Valencia, Spain.

Fig. 1. Capsule endoscopy findings. A and C. A circumferential, stricturing and ulcerated lesion was found. B. Oozing active bleeding from the lesion.

A

B C

Page 2: Jejunal plasmablastic lymphoma presenting as obscure overt ...scielo.isciii.es/pdf/diges/v107n9/imagenes1.pdf · There are few case reports of plasmablastic lymphoma (PBL) which had

568 P. MAGALHÃES-COSTA ET AL. Rev esp enfeRm Dig (maDRiD)

Rev esp enfeRm Dig 2015; 107 (9): 567-568

REFERENCES

1. Cha JM, Lee J Il, Joo KR, Jung SW, Shin HP, Lee JJ, et al. A case report with plasmablastic lymphoma of the jejunum. J Korean Med Sci 2010;25:496-500.

2. Bahari A, Jahantigh M, Mashhadi A, Bari Z, Bari A. Plasmablastic lymphoma presenting as small intestinal polyposis: A case-report. Iran Red Crescent Med J 2012;14:669-75.

3. Wang H-W, Yang W, Sun J-Z, Lu J-Y, Li M, Sun L. Plasmablastic lymphoma of the small intestine: Case report and literature review. World J Gastroenterol. 2012;18:6677-81.

Fig. 2. Radiological images of a jejunal mass. A. CT scan (transverse plan): Small-bowel mass in the pelvic cavity. The retained capsule endoscopy device (hollow arrow). B. CT scan (coronal plan): Small-bowel mass in the pelvic cavity (6.9x6.7 cm) with cleavage plan with the surrounding structures.

Fig. 3. Histopathology of plasmablastic lymphoma. A. (H&E, 40x). Diffuse infiltration in the mucosa of the small-bowel by monotonous large atypical lymphoid cells. B. (H&E, 400x). These cells displayed a large nucleus, a prominent centrally located nucleoli, abundant basophilic cytoplasm and high mitotic index. C. IHQ (CD138): Positive (plasmocytic differentiation). D. IHQ (CD79a): Positive (B-cell lineage). E. IHQ (CD20): Negative (typical B-cell antigen).

BA

C D

E

A

B